NA Bioinformatics Market - Industry Trends Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143121
- Pages: 225
-
Format:
Short Description:
North America bioinformatics market, By Type (Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform)) Biological data interpretation, specialized bioinformatics application (single cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression and others), Services), Sector (medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology and others), Application( Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services), Purchase mode (group purchase and individual purchase), Genomics (Genomics (DNA and RNA), Proteomics) End User (Research and academic institute, Clinical research organization, biotech and pharmaceutical companies, research laboratories, hospitals and Others.) Country (U.S., Canada, Mexico) Industry Trends & Forecast to 2029.
Market Definition:
Bioinformatics, which is connected to genetics and genomics, uses computer technology to gather, store, analyze, and share biological data and information, such as DNA and amino acid sequences or annotations about those sequences. The three components of bioinformatics are building databases, creating statistics and algorithms, data analysis, and interpretation. Identification of genes and proteins, as well as their functions, evolutionary relationships, and conformation prediction, are the main goals.
For instance,
In 2021, Agilent unveiled Sure-Select Human All Exon V8, a novel exome design that offers thorough content and coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes
In October 2020, SOPHiA GENETICS, raised USD 110 million, for financing into the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Data-Driven Medicine worldwide
The drivers responsible for the growth of the North America bioinformatics market are increased prevalence of use of bioinformatics equipment, decrease in the cost of genetic sequencing per base, technological advancements in the bioinformatics devices, and wide product portfolio offered by major players. However, the rise in the cost of devices, risks observed while using the devices, difficulty in using bioinformatics devices, and cybersecurity concerns in bioinformatics is expected to restrain the market growth.
On the other hand, strategic initiatives by key players, a rise in healthcare expenditure, and an increase in research and development activities may act as an opportunity for the growth of the global bioinformatics market. However, the need for skilled expertise and regulatory approval may create challenges for the global bioinformatics market.
Market Segmentation:
The North America bioinformatics market is categorized into six segments: type, sector, application, purchase mode, genomics, and end user.
On the basis of type, the North America bioinformatics market is segmented into Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform) Biological data interpretation, specialized bioinformatics application (single-cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression, and others), Services)
On the basis of sector, the North America bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.
On the basis of application, Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics, and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services).
On the basis of purchase mode, the North America bioinformatics market is segmented into group purchases and individual purchases.
On the basis of genomics, the North America bioinformatics market is segmented into Genomics (DNA and RNA) and Proteomics.
On the basis of end-user, the North America bioinformatics market is segmented into Research and academic institute, Clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.
Market Players:
The key market players operating in the North America bioinformatics market are listed below:
Thermo Fisher Scientific
Illumina, Inc
Agilent Technologies, Inc
QIAGEN
SOPHiA GENETICS
BGI
Bayer AG
DNANEXUS, INC
PerkinElmer Inc.
Seven Bridges Genomics
Quest Diagnostics Incorporated
AstridBio Technologies Inc
BioBam
Strand Life Sciences
GenoFAB, Inc
TABLE OF CONTENTS
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 OVERVIEW OF THE NORTH AMERICA BIOINFORMATICS MARKET 19
1.4 CURRENCY AND PRICING 22
1.5 LIMITATION 22
1.6 MARKETS COVERED 22
2 MARKET SEGMENTATION 26
2.1 MARKETS COVERED 26
2.2 GEOGRAPHIC SCOPE 27
2.3 YEARS CONSIDERED FOR THE STUDY 28
2.4 CURRENCY AND PRICING 28
2.5 RESEARCH METHODOLOGY 29
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.7 MULTIVARIATE MODELLING 33
2.8 TYPE SEGMENT LIFELINE CURVE 33
2.9 DBMR MARKET POSITION GRID 34
2.10 VENDOR SHARE ANALYSIS 36
2.11 MARKET APPLICATION COVERAGE GRID 37
2.12 THE CATEGORY VS TIME GRID 38
2.13 SECONDARY SOURCES 39
2.14 ASSUMPTIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 44
4.1 PESTEL 46
4.2 PORTER'S FIVE FORCES MODEL 47
5 REGULATIONS OF THE NORTH AMERICA BIOINFORMATICS MARKET 48
6 MARKET OVERVIEW 51
6.1 DRIVERS 53
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE 53
6.1.2 GROWING NEED FOR BIOINFORMATICS 54
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS 55
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE 56
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 56
6.2 RESTRAINTS 57
6.2.1 HIGH COST OF INSTRUMENTATION 57
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS 57
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS 58
6.3 OPPORTUNITIES 58
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 58
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS 59
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 59
6.4 CHALLENGES 60
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY 60
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS 60
7 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE 62
7.1 OVERVIEW 63
7.2 SERVICES 66
7.2.1 DIAGNOSTICS CONSULTATION 67
7.2.2 DATA ANALYSIS 67
7.2.2.1 STRUCTURAL 67
7.2.2.2 FUNCTIONAL 67
7.3 BIOINFORMATICS SOFTWARE 67
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP 69
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT 69
7.3.3 SEQUENCING DATA ANALYSIS 69
7.3.3.1 SEQUENCE ANALYSIS PLATFORM 70
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM 70
7.3.3.3 SEQUENCE MANIPULATION PLATFORM 70
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM 70
7.3.3.5 OTHERS 70
7.3.4 BIOLOGICAL DATA INTERPRETATION 70
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS 71
7.3.5.1 SINGLE CELL GENE EXPRESSION 71
7.3.5.2 GENE EXPRESSION 71
7.3.5.3 VARIANT DETECTION 71
7.3.5.4 CNV ANALYSIS 71
7.3.5.5 METAGENOMICS 72
7.3.5.6 METHYLATION 72
7.3.5.7 CHIP-SEQ 72
7.3.5.8 NON-CODING RNA EXPRESSION 72
7.3.5.9 OTHERS 72
7.3.6 OTHERS 72
7.4 KNOWLEDGE MANAGEMENT TOOLS 72
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 73
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 73
8 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR 74
8.1 OVERVIEW 75
8.2 MEDICAL BIOTECHNOLOGY 78
8.3 ACADEMICS 79
8.4 ANIMAL BIOTECHNOLOGY 80
8.5 AGRICULTURAL BIOTECHNOLOGY 80
8.6 ENVIRONMENTAL BIOTECHNOLOGY 81
8.7 FORENSIC BIOTECHNOLOGY 82
8.8 OTHERS 83
9 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION 84
9.1 OVERVIEW 85
9.2 GENOMICS & DRUG DEVELOPMENT 88
9.2.1 SERVICES 89
9.2.2 SEQUENCING PLATFORMS 89
9.2.3 KNOWLEDGE MANAGEMENT TOOLS 89
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE 90
9.2.4.1 PREVENTIVE MEDICINE 90
9.2.4.2 MOLECULAR MEDICINE 90
9.2.4.3 PERSONALIZED MEDICINE 90
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN 90
9.2.4.5 ANTIBIOTIC RESISTANCE 90
9.3 PROTEOMICS 90
9.3.1 SERVICES 92
9.3.2 SERVICES SEQUENCING PLATFORMS 92
9.3.3 KNOWLEDGE MANAGEMENT TOOLS 92
9.4 AGRICULTURAL STUDIES 92
9.4.1 SERVICES 94
9.4.2 SERVICES SEQUENCING PLATFORMS 94
9.4.3 KNOWLEDGE MANAGEMENT TOOLS 94
9.5 TRANSCRIPTOMICS 94
9.5.1 SERVICES 95
9.5.2 SERVICES SEQUENCING PLATFORMS 95
9.5.3 KNOWLEDGE MANAGEMENT TOOLS 95
9.6 METABOLOMICS 95
9.6.1 SERVICES 97
9.6.2 SERVICES SEQUENCING PLATFORMS 97
9.6.3 KNOWLEDGE MANAGEMENT TOOLS 97
9.7 EVOLUTIONARY STUDIES 97
9.7.1 SERVICES 98
9.7.2 SERVICES SEQUENCING PLATFORMS 98
9.7.3 KNOWLEDGE MANAGEMENT TOOLS 98
9.8 VETERINARY SCIENCE 98
9.8.1 SERVICES 100
9.8.2 SERVICES SEQUENCING PLATFORMS 100
9.8.3 KNOWLEDGE MANAGEMENT TOOLS 100
9.9 OTHERS 100
9.9.1 SERVICES 102
9.9.2 SERVICES SEQUENCING PLATFORMS 102
9.9.3 KNOWLEDGE MANAGEMENT TOOLS 102
10 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE 103
10.1 OVERVIEW 104
10.2 GROUP PURCHASE 107
10.3 INDIVIDUAL PURCHASE 107
11 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD 109
11.1 OVERVIEW 110
11.2 GENOMICS 113
11.2.1 DNA 114
11.2.2 RNA 114
11.3 PROTEOMICS 114
12 NORTH AMERICA BIOINFORMATICS MARKET, BY END USER 116
12.1 OVERVIEW 117
12.2 RESEARCH AND ACADEMIC INSTITUTES 120
12.3 CLINICAL RESEARCH ORGANIZATION 120
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES 121
12.5 RESEARCH LABORATORIES 122
12.6 HOSPITALS 123
12.7 OTHERS 124
13 NORTH AMERICA BIOINFORMATICS MARKET, BY REGION 125
13.1 NORTH AMERICA 126
13.1.1 U.S. 136
13.1.2 CANADA 142
13.1.3 MEXICO 148
14 NORTH AMERICA BIOINFORMATICS MARKET: COMPANY LANDSCAPE 154
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 154
15 SWOT ANALYSIS 155
16 COMPANY PROFILE 156
16.1 BAYER AG 156
16.1.1 COMPANY SNAPSHOT 156
16.1.2 REVENUE ANALYSIS 156
16.1.3 COMPANY SHARE ANALYSIS 157
16.1.4 PRODUCT PORTFOLIO 157
16.1.5 RECENT DEVELOPMENTS 157
16.2 THERMO FISHER SCIENTIFIC INC 158
16.2.1 COMPANY SNAPSHOT 158
16.2.2 REVENUE ANALYSIS 158
16.2.3 COMPANY SHARE ANALYSIS 159
16.2.4 PRODUCT PORTFOLIO 159
16.2.5 RECENT DEVELOPMENTS 159
16.3 EUROFINS SCIENTIFIC 160
16.3.1 COMPANY SNAPSHOT 160
16.3.2 REVENUE ANALYSIS 160
16.3.3 COMPANY SHARE ANALYSIS 161
16.3.4 PRODUCT PORTFOLIO 161
16.3.5 RECENT DEVELOPMENTS 161
16.4 DASSAULT SYSTMES 162
16.4.1 COMPANY SNAPSHOT 162
16.4.2 REVENUE ANALYSIS 162
16.4.3 COMPANY SHARE ANALYSIS 163
16.4.4 PRODUCT PORTFOLIO 163
16.4.5 RECENT DEVELOPMENTS 163
16.5 AGILENT TECHNOLOGIES, INC 164
16.5.1 COMPANY SNAPSHOT 164
16.5.2 REVENUE ANALYSIS 164
16.5.3 COMPANY SHARE ANALYSIS 165
16.5.4 PRODUCT PORTFOLIO 165
16.5.5 RECENT DEVELOPMENTS 166
16.6 ASTRIDBIO TECHNOLOGIES INC. 167
16.6.1 COMPANY SNAPSHOT 167
16.6.2 PRODUCT PORTFOLIO 167
16.6.3 RECENT DEVELOPMENTS 167
16.7 BGI (A SUBSIDIARY OF BGI GROUP) 168
16.7.1 COMPANY SNAPSHOT 168
16.7.2 PRODUCT PORTFOLIO 168
16.7.3 RECENT DEVELOPMENTS 169
16.8 BIOBAM 170
16.8.1 COMPANY SNAPSHOT 170
16.8.2 PRODUCT PORTFOLIO 170
16.8.3 RECENT DEVELOPMENTS 170
16.9 DNANEXUS INC. 172
16.9.1 COMPANY SNAPSHOT 172
16.9.2 PRODUCT PORTFOLIO 172
16.9.3 RECENT DEVELOPMENTS 172
16.10 DNASTAR 173
16.10.1 COMPANY SNAPSHOT 173
16.10.2 PRODUCT PORTFOLIO 173
16.10.3 RECENT DEVELOPMENTS 173
16.11 GENOFAB, INC 174
16.11.1 COMPANY SNAPSHOT 174
16.11.2 PRODUCT PORTFOLIO 174
16.11.3 RECENT DEVELOPMENTS 174
16.12 ILLUMINA, INC 175
16.12.1 COMPANY SNAPSHOT 175
16.12.2 REVENUE ANALYSIS 175
16.12.3 PRODUCT PORTFOLIO 176
16.12.4 RECENT DEVELOPMENTS 176
16.13 PARTEK INCORPORATED 177
16.13.1 COMPANY SNAPSHOT 177
16.13.2 PRODUCT PORTFOLIO 177
16.13.3 RECENT DEVELOPMENTS 177
16.14 PERKINELMER INC. 178
16.14.1 COMPANY SNAPSHOT 178
16.14.2 PRODUCT PORTFOLIO 178
16.14.3 RECENT DEVELOPMENTS 179
16.15 QIAGEN 180
16.15.1 COMPANY SNAPSHOT 180
16.15.2 REVENUE ANALYSIS 180
16.15.3 PRODUCT PORTFOLIO 180
16.15.4 RECENT DEVELOPMENTS 181
16.16 QUEST DIAGNOSTICS INCORPORATED (2021) 182
16.16.1 COMPANY SNAPSHOT 182
16.16.2 REVENUE ANALYSIS 182
16.16.3 PRODUCT PORTFOLIO 183
16.16.4 RECENT DEVELOPMENTS 183
16.17 SEVEN BRIDGES GENOMICS 184
16.17.1 COMPANY SNAPSHOT 184
16.17.2 PRODUCT PORTFOLIO 184
16.17.3 RECENT DEVELOPMENTS 184
16.18 SOPHIA GENETICS 185
16.18.1 COMPANY SNAPSHOT 185
16.18.2 REVENUE ANALYSIS 185
16.18.3 PRODUCT PORTFOLIO 186
16.18.4 RECENT DEVELOPMENTS 186
16.19 STRAND LIFE SCIENCES 187
16.19.1 COMPANY SNAPSHOT 187
16.19.2 PRODUCT PORTFOLIO 187
16.19.3 RECENT DEVELOPMENTS 188
16.20 WATERS CORPORATION 189
16.20.1 COMPANY SNAPSHOT 189
16.20.2 PRODUCT PORTFOLIO 189
16.20.3 RECENT DEVELOPMENTS 189
17 QUESTIONNAIRE 190
18 RELATED REPORTS 194
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
